LAVA Therapeutics (LVTX) Earnings Date, Estimates & Call Transcripts $0.96 +0.02 (+2.41%) Closing price 02/21/2025 03:49 PM EasternExtended Trading$0.97 +0.01 (+1.31%) As of 02/21/2025 06:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends LAVA Therapeutics Latest Earnings SummaryUpcoming Q4 Earnings DateMar. 19Before Market OpensEstimatedActual EPS (Dec. 10) -$0.46 Missed By -$0.11 Consensus EPS (Dec. 10) -$0.35 LAVA Therapeutics posted Q3 2024 earnings on December 10, 2024, reporting an EPS of -$0.46, which missed the consensus estimate of -$0.35 by $0.11. With a trailing EPS of -$1.03, LAVA Therapeutics' earnings are expected to decrease next year, from ($1.13) to ($1.30) per share. LVTX Upcoming EarningsLAVA Therapeutics' next earnings date is estimated for Wednesday, March 19, 2025, based off prior year's reporting schedules. Get LAVA Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on LAVA Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataLVTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.LVTX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. LAVA Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.23-$0.23-$0.23Q2 20251-$0.23-$0.23-$0.23Q3 20251-$0.22-$0.22-$0.22Q4 20251-$0.23-$0.23-$0.23FY 20254($0.91)($0.91)($0.91) LAVA Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 3/19/2025(Estimated)-------12/10/2024Q3 2024-$0.35-$0.46 -$0.11-$0.46--8/20/2024Q2 2024-$0.36-$0.31+$0.05-$0.31--5/21/2024Q1 2024-$0.25-$0.02+$0.23-$0.02-$6.99M3/20/2024Q4 2023$0.16-$0.24 -$0.40-$0.24$25.00M$0.35M11/16/2023Q3 2023-$0.49-$0.34+$0.15-$0.34-$0.05M8/22/2023Q2 2023-$0.50-$0.48+$0.02-$0.48$2.50M$5.14M6/8/2023Q1 2023-$0.49-$0.53 -$0.04-$0.53-$1.22M4/11/2023Q4 2022--$0.57 -$0.57-$0.57-$2.64M LAVA Therapeutics Earnings - Frequently Asked Questions When is LAVA Therapeutics's earnings date? LAVA Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 19th, 2025 based off last year's report dates. Learn more on LVTX's earnings history. Did LAVA Therapeutics beat their earnings estimates last quarter? In the previous quarter, LAVA Therapeutics (NASDAQ:LVTX) missed the analysts' consensus estimate of ($0.35) by $0.11 with a reported earnings per share (EPS) of ($0.46). Learn more on analysts' earnings estimate vs. LVTX's actual earnings. How much revenue does LAVA Therapeutics generate each year? LAVA Therapeutics (NASDAQ:LVTX) has a recorded annual revenue of $6.77 million. How much profit does LAVA Therapeutics generate each year? LAVA Therapeutics (NASDAQ:LVTX) has a recorded net income of -$41.97 million. LVTX has generated -$1.03 earnings per share over the last four quarters. What is LAVA Therapeutics's EPS forecast for next year? LAVA Therapeutics's earnings are expected to decrease from ($1.13) per share to ($1.30) per share in the next year. More Earnings Resources from MarketBeat Related Companies Metagenomi Earnings Date Elutia Earnings Date Janone Earnings Date Oramed Pharmaceuticals Earnings Date MediciNova Earnings Date Skye Bioscience Earnings Date Tenaya Therapeutics Earnings Date Cue Biopharma Earnings Date Vor Biopharma Earnings Date SELLAS Life Sciences Group Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles The Trade Desk Crashes on Earnings, But Growth Catalysts PersistHims & Hers Earnings Could Be a Game Changer—What to Do NowAnalysts See Buying Opportunity in NVIDIA Before EarningsAirbnb's Earnings: Sky High Results, Grounded Guidance?Is Coinbase Stock a Buy After Earnings?CVS Health: Earnings Beat Ignites Stock RallyQualcomm’s Post-Earnings Dip: A Prime Buying Opportunity? This page (NASDAQ:LVTX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LAVA Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share LAVA Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
